Kidney Function Tests Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Kidney Function Tests Market
Kidney Function Tests Market: By Product (Clearance Tests, Dilution, Concentration Tests, Urine Tests, and Visual Imaging Tests) & By Region-Forecast (2016-2021)
Report Code : HCR 0235
Published: 01 March, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
Kidneys reabsorb the essential elements and remove the water-soluble waste products from the blood and hence are among the most vital organs of the human body. The incidence of functional damage of the kidney is common across the world. According to the WHO estimates, more than 1.4 million people worldwide undergo renal replacement therapy every year which results into considerable increase in the incidence rate of chronic kidney disease. The symptoms which indicate a problem related to kidneys include high blood pressure, blood in urine, difficulty in urination, frequent urges to urinate, and swelling in the hands and feet. Globally, growing number of individuals suffering from chronic kidney disease, rise in the aging population, and increasing incidences and prevalence of diabetes are the prime growth drivers of global kidney function tests market. In addition, increase in incidence rate of renal fibrosis, and emerging economies such as China, India and others, will create new opportunities for global kidney function tests market. However, higher cost of treatment and stringent regulatory approvals are the key restraints for global kidney function tests market.

This report identifies the global kidney function tests market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global kidney function tests market.
 
Kidney Function Tests Market

Geographically North America dominated global kidney function tests market, and Asia Pacific is projected to have fastest growth, owing to higher incidence rate of chronic diseases, growing patient awareness and rising demand for advanced diagnostics and therapeutics regimens for chronic kidney diseases in developing nations such as China, and India in this region. Among all the test types, concentration tests have the highest market share in global kidney function tests market.

This report segments global kidney function tests market on the basis of test types and regional market as follows:
  • Kidney Function Tests Market, By Test Types: Clearance Tests, Dilution, Concentration Tests, Urine Tests, and Visual Imaging Tests
  • This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the kidney function tests market. Some of the major companies’ profiles in detail are as follows:
  • Metabolic Solutions Development Company, LLC
  • F. Hoffmann-La Roche Ltd
  • Otsuka Holdings Co., Ltd.
  • Eli Lilly and Company
  • Kadmon Corporation, LLC
1. Kidney Function Tests Market – Market Overview
2. Executive Summary
3. Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Kidney Function Tests Market– Market Forces
   4.1. Drivers
      4.1.1. Growing number of individuals suffering from chronic kidney disease
      4.1.2. Rise in the aging population
      4.1.3. Increasing incidences and prevalence of diabetes
   4.2. Restraints
      4.2.1. Higher cost of treatment
      4.2.2. Stringent regulatory approvals
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in incidence rate of renal fibrosis
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Kidney Function Tests Market, By Test Type
   5.1. Clearance Tests
   5.2. Dilution
   5.3. Concentration Tests
   5.4. Urine Tests
   5.5. Visual Imaging Tests
6. Kidney Function Tests Market, By Geography
   6.1. Europe
      6.1.1. Germany
      6.1.2. France
      6.1.3. Italy
      6.1.4. Spain
      6.1.5. Russia
      6.1.6. U.K.
      6.1.7. Rest of Europe
   6.2. Asia Pacific
      6.2.1. China
      6.2.2. India
      6.2.3. Japan
      6.2.4. South Korea
      6.2.5. Rest of Asia-Pacific
   6.3. North America
      6.3.1. U.S.
      6.3.2. Canada
      6.3.3. Mexico
   6.4. Rest of the World (RoW)
      6.4.1. Brazil
      6.4.2. Rest of RoW
7. Kidney Function Tests – Market Entropy
   7.1. Expansion
   7.2. Technological Developments
   7.3. Merger & Acquisitions, and Joint Ventures
   7.4. Supply- Contract
8. Company Profiles (By- Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   8.1. Metabolic Solutions Development Company, LLC
   8.2.  F. Hoffmann-La Roche Ltd
   8.3. Otsuka Holdings Co., Ltd.
   8.4. Eli Lilly and Company
   8.5. Kadmon Corporation, LLC
   8.6. Baxter International Inc.
   8.7. Ipsen S.A.
   8.8. Galectin Therapeutics, Inc.
   8.9. Pfizer Inc.
   8.10. IC-Meditech, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
9. Appendix

   9.1. Abbreviations
   9.2. Sources
   9.3. Research Methodology
   9.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll